European Peptide Therapeutics Market Share 2021: Trends, Key Players, Industry Analysis and Report 2021-2027

The European peptide therapeutics market will see a considerable growth of 4.3% during the forecast period. The region has a significant presence of peptide therapeutics industry players, with extensive R&D in the market. With the increase in the number of cases of cancer in the region, the demand for proper treatment and availability of drugs is expected to rise; thereby, augmenting the growth of peptide therapeutics for cancer treatment.

Moreover, well-developed healthcare infrastructure is also estimated to surge the adoption of various healthcare facilities in the region. Further, the surging need for early disease diagnosis in the region is supporting the growth of the peptide therapeutics market.

A full report of European Peptide Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/european-peptide-therapeutics-market

Another factor that encourages the growth of the market includes the rising mortality rate from respiratory disorders across the region. As per the Organization For Economic Co-Operation and Development, the self-reported COPD and asthma rates were 4.0% and 6.1% respectively in European Union countries.

Moreover, it has been found that the prevalence rate of diseases is higher in women as compared to men. As per the OECD 2019, respiratory diseases are a major cause of death accounting for 10% of deaths across all OECD countries. COPD accounted for 4% of all deaths globally. Smoking is the main factor that leads to COPD, and occupational exposure to dust, fumes, and chemicals, and air pollution, in general, are also important risk factors. Thus, rising mortalities due to respiratory disorders create a scope for the growth of the market over the forecast period.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/european-peptide-therapeutics-market

Market Coverage

• Study Period- 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segments Covered- By Route of Administration and By Application
• Countries Covered- UK, Germany, Italy, France, Spain, Rest of Europe
• Key Companies Profiled- Novo Nordisk A/S, Eli Lilly & Co., AstraZeneca Plc, CordenPharma International GmbH, Bachem Holding AG, and Sanofi SA

Key questions addressed by the report

• What is the market growth rate during the forecast period?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market during the forecast period?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

European Peptide Therapeutics Market – Segmentation

By Route of Administration

• Oral
• Parenteral

By Application

• Cancer
• Gastrointestinal Disorders
• Central Nervous System Disorders
• Respiratory Disorders
• Others

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/european-peptide-therapeutics-market

European Peptide Therapeutics Market – Segment by Region

• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Company Profiles

• AstraZeneca PLC
• BachemHolding AG
• CordenPharmaInternational GmbH
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline PLC
• Novartis International AG
• Novo Nordisk A/S
• Pfizer Inc.
• Sanofi SA

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.